Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigulixostat and Colchicine Interaction Study
NCT03927677Phase 1Completed
- Sponsor
- LG Chem
- Start
- Nov 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tigulixostat in gout and hyperuricemia, sponsored by LG Chem. Primary endpoints: Maximum observed concentration, Area under the concentration-time curve and 1 more. Started Nov 2019; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT03927677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03927677.